ROIV – roivant sciences ltd. (US:NASDAQ)
Stock Stats
News
Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? [Yahoo! Finance]
Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
Roivant Sciences Ltd. (NASDAQ: ROIV) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna [Yahoo! Finance]
Form 4 Roivant Sciences Ltd. For: Mar 28 Filed by: Pulik Richard
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Venker Eric
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Gline Matthew
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Pulik Richard
Form 4 Roivant Sciences Ltd. For: Mar 20 Filed by: Humes Jennifer
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.